Schonfeld Strategic Advisors LLC Intellia Therapeutics, Inc. Transaction History

Schonfeld Strategic Advisors LLC

$13.8 Billion
Q3 2024

A detailed history of Schonfeld Strategic Advisors LLC transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 135,279 shares of NTLA stock, worth $1.63 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

135,279

Previous 186,440 27.44%

Holding current value

$1.63 Million

Previous $4.17 Million 33.39%

% of portfolio

0.02%

Previous 0.03%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$19.72 - $27.36 $1.01 Million - $1.4 Million	-51,161 Reduced 27.44%	135,279 $2.78 Million
Q2 2024 Aug 14, 2024	BUY	$20.02 - $27.22 $3.22 Million - $4.37 Million	160,719 Added 624.86%	186,440 $4.17 Million
Q1 2024 May 15, 2024	BUY	$23.82 - $32.8 $612,674 - $843,648	25,721 New	25,721 $707,000
Q3 2023 Nov 14, 2023	SELL	$31.62 - $45.78 $1.24 Million - $1.79 Million	-39,118 Reduced 78.11%	10,960 $346,000
Q2 2023 Aug 14, 2023	BUY	$34.58 - $46.03 $444,387 - $591,531	12,851 Added 34.52%	50,078 $2.04 Million
Q1 2023 May 15, 2023	BUY	$33.3 - $44.82 $1.24 Million - $1.67 Million	37,227 New	37,227 $1.39 Million
Q3 2022 Nov 14, 2022	SELL	$53.92 - $71.7 $1.24 Million - $1.64 Million	-22,930 Reduced 51.07%	21,970 $1.23 Million
Q2 2022 Aug 15, 2022	BUY	$38.49 - $76.21 $808,290 - $1.6 Million	21,000 Added 87.87%	44,900 $2.32 Million
Q1 2022 May 16, 2022	BUY	$58.27 - $118.99 $1.39 Million - $2.84 Million	23,900 New	23,900 $1.74 Million
Q3 2021 Nov 16, 2021	SELL	$132.37 - $176.78 $661,850 - $883,900	-5,000 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$60.88 - $161.91 $304,400 - $809,550	5,000 New	5,000 $810,000
Q1 2021 May 17, 2021	SELL	$46.59 - $83.68 $1.49 Million - $2.67 Million	-31,880 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$18.83 - $63.53 $600,300 - $2.03 Million	31,880 New	31,880 $1.73 Million
Q1 2018 May 15, 2018	SELL	$19.43 - $34.95 $221,968 - $399,268	-11,424 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$17.39 - $31.12 $198,663 - $355,514	11,424	11,424 $220,000

Others Institutions Holding NTLA

# of Institutions

314

Shares Held

91.5M

Call Options Held

442K

Put Options Held

880K

View Full List

About Intellia Therapeutics, Inc.

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $916M
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

More about NTLA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.

Account

Schonfeld Strategic Advisors LLC Intellia Therapeutics, Inc. Transaction History